| Literature DB >> 35159482 |
Ahmed M Hammad1, Amira Eltahan1, Hamdy A Hassan2,3, Nasser H Abbas2, Heba Hussien1, Tadashi Shimamoto4.
Abstract
The aim of this study was to assess the hygienic status of raw milk cheese and determine the trends of virulence and antimicrobial resistance in thermotolerant Escherichia coli. Two hundred samples of karish, a popular Egyptian fresh raw milk cheese, were analyzed for coliforms and fecal coliforms using a standard most probable number (MPN) technique. Overall, 85% of samples were unsuitable for consumption, as they exceeded Egyptian standards for coliforms (10 MPN/g), and 65% of samples exhibited coliforms at 44.5 °C. Of 150 recovered thermotolerant strains, 140 (93.3%) were identified as E. coli. Importantly, one Shiga toxin-producing E. coli (STEC) strain carrying a striking virulence pattern, stx1-, stx2+, eae-, was detected. Eleven strains (7.8%, 11/140) showed resistance to third-generation cephalosporins. Antibiotic resistance genes included blaSHV, blaCTX-M, qnrS, tet(A), and tet(B), which were present in 4.3%, 2.8%, 0.71%, 2.1%, and 0.71% of isolates, respectively. In conclusion, this study indicated that hygienic-sanitary failures occurred throughout the production process of most retail karish cheese. Furthermore, our findings emphasize the need for adopting third-generation cephalosporin-resistant E. coli as an indicator for monitoring antimicrobial resistance in raw milk cheese to identify the potential public health burden associated with its consumption.Entities:
Keywords: Shiga toxin-producing E. coli (STEC); antibiotic resistance; cheese; thermotolerant coliforms; virulence
Year: 2022 PMID: 35159482 PMCID: PMC8834472 DOI: 10.3390/foods11030332
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Violin plots overlaid on box and whisker plots showing the distribution of log 10 MPN/g of coliforms and fecal coliforms in raw milk cheese samples. The box represents 50% of data values, and the horizontal line within the box signifies the median. The upper and lower boundaries of the box are the 75th and 25th percentile, respectively. The whiskers (error bars) above and below the box represent the highest and lowest values within 1.5 times the interquartile range and indicate the 90th percentiles and 10th percentiles, respectively. White spots represent the outliers. The width of the violin plot reveals the frequency of samples.
Figure 2Heatmap showing antibiotic resistance profiles of thermotolerant E. coli strains. The numbers of strains are on the right of the heat map, followed by the identified antibiotic resistance genes. The dark blue color of the box indicates the resistance to the antimicrobial, while the white color indicates the susceptibility to the antimicrobial. The dendrogram on the left reflects the hierarchical clustering of antibiotic resistance profiles in the isolated strains. The numbers on the dendrogram (1 to 3) indicate the numbers of clusters. The dendrogram on the top reflects the hierarchical clustering of screened antibiotics. Abbreviations of the antimicrobials are AMC, amoxicillin-clavulanic acid; AMP, ampicillin; CAZ, ceftazidime; CFM, cefixime; CIP, ciprofloxacin; CRO, ceftriaxone; CTX, cefotaxime; GEN, gentamicin; NAL, nalidixic acid; STR, streptomycin; SXT, sulfamethoxazole-trimethoprim and TET, tetracycline.
Figure 3Heatmap showing virulence profiles of our strain and published strains isolated from raw milk cheeses in different countries in the last decade. All virulence patterns discovered in each of the 17 investigations were depicted once, regardless of their frequency. The dark blue color of the box indicates the presence of the gene, while the white color indicates the absence of the gene. On the right side of the heatmap, the country of origin of each strain and the year of publication of each study were written. The following studies were included: Study 1 [48]; Study 2 [49]; Study 3 [50]; Study 4 [51]; Study 5 [39]; Study 6 [42]; Study 7 [52]; Study 8 [53]; Study 9 [27]; Study 10 [54]; Study 11 [29]; Study 12 [40]; Study 13 [55]; Study 14 [56]; Study 15 [57]; Study 16 [41]; and Study 17 [58].